Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Status:
Terminated
Trial end date:
2010-09-22
Target enrollment:
Participant gender:
Summary
The underlying goal of this study is to assess [18F] PBR06 PET imaging as a tool to detect
microglial activation in the brain of Alzheimer Disease (AD), Parkinson Disease (PD) and
Multiple Sclerosis (MS) research participants.